New Medicines Fluor Secures 1 Billion Dollar Plus Contracts in Life Sciences Industry

Source: Press release Fluor Corporation 1 min Reading Time

Related Vendors

Fluor has bagged two contracts – one for a biotech expansion project in Denmark worth 487-million-dollars and another for the first phase of a new life sciences production facility valued at 574-million-dollars in central U.S.

Fluor will recognize these reimbursable contracts in the second quarter backlog.(Source:  Pixabay)
Fluor will recognize these reimbursable contracts in the second quarter backlog.
(Source: Pixabay)

Texas/USA – Fluor Corporation has recently been awarded a 487-million-dollar biotech expansion project in Denmark and is also mobilizing resources in central U.S. for the first phase of a new life sciences production facility valued at 574-million-dollars. Fluor will recognize these reimbursable contracts in the second quarter backlog.

“We are excited to see the significant investments being made globally in the production of cutting-edge technologies and pharmaceuticals that will improve the lives of billions of people,” said Richard Meserole, president of Fluor’s Advanced Technologies & Life Sciences business. “Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines.”

(ID:49629107)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent